Literature DB >> 29518365

RACK1 upregulation induces neuroprotection by activating the IRE1-XBP1 signaling pathway following traumatic brain injury in rats.

Haibo Ni1, Qin Rui2, Yitian Xu3, Jun Zhu4, Fan Gao5, Baoqi Dang5, Di Li6, Rong Gao7, Gang Chen8.   

Abstract

Receptor for activated protein kinase C 1 (RACK1) is a multifaceted scaffolding protein known to be involved in the regulation of signaling events required for neuronal protection. In the present study, we investigated the role of RACK1 in secondary brain injury in a rat traumatic brain injury (TBI) model. A weight-drop TBI model was established in Sprague Dawley rats, and RACK1 in vivo knockdown and overexpression were performed 24 h before TBI insult. The IRE1 inhibitor 3,5-dibromosalicylaldehyde (DBSA) was administered by intracerebroventricular injection 1 h after TBI insult. Real-time PCR, Western blotting, immunofluorescence, neuronal apoptosis, brain water content, and neurological scores were evaluated. Our results revealed that TBI induced increased expression of endogenous RACK1, phosphorylated inositol-requiring enzyme 1 (p-IRE1), X-box binding protein-1 (XBP1) and glucose-regulated protein 78 (GRP78) in neurons. RACK1 overexpression significantly ameliorated neuronal apoptosis, blood-brain barrier disruption, brain edema and neurological deficits at 48 h after TBI, which was concomitant with upregulation of p-IRE1, XBP1 and GRP78 expression, while its knockdown induced the opposite effects. Furthermore, DBSA administration reversed the protective effects of RACK1 overexpression against brain injury and decreased the expression of p-IRE1, XBP1 and GRP78. In summary, the upregulation of RACK1 following brain contusion exerted neuroprotective effects against secondary brain injury, which were probably mediated by activation of the IRE1-XBP1 pathway.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  IRE1; Neuroprotection; RACK1; Secondary brain injury; Traumatic brain injury; XBP1

Mesh:

Substances:

Year:  2018        PMID: 29518365     DOI: 10.1016/j.expneurol.2018.03.003

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  5 in total

Review 1.  Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets.

Authors:  Komal Thapa; Heena Khan; Thakur Gurjeet Singh; Amarjot Kaur
Journal:  J Mol Neurosci       Date:  2021-05-06       Impact factor: 3.444

2.  Neuroprotection Effect of Astragaloside IV from 2-DG-Induced Endoplasmic Reticulum Stress.

Authors:  Yu Fu; Jianhang Cai; Mengyao Xi; Yifei He; Yang Zhao; Yi Zheng; Yidong Zhang; Jinkun Xi; Yonggui He
Journal:  Oxid Med Cell Longev       Date:  2020-12-31       Impact factor: 6.543

Review 3.  Endogenous Mechanisms of Neuroprotection: To Boost or Not to Boost.

Authors:  Sara Marmolejo-Martínez-Artesero; Caty Casas; David Romeo-Guitart
Journal:  Cells       Date:  2021-02-10       Impact factor: 6.600

Review 4.  Proteostasis Deregulation in Neurodegeneration and Its Link with Stress Granules: Focus on the Scaffold and Ribosomal Protein RACK1.

Authors:  Mirco Masi; Alessandro Attanzio; Marco Racchi; Benjamin Wolozin; Sofia Borella; Fabrizio Biundo; Erica Buoso
Journal:  Cells       Date:  2022-08-19       Impact factor: 7.666

5.  Dual role of RACK1 in airway epithelial mesenchymal transition and apoptosis.

Authors:  Yue Pu; Yuan-Qi Liu; Yan Zhou; Yi-Fan Qi; Shi-Ping Liao; Shi-Kun Miao; Li-Ming Zhou; Li-Hong Wan
Journal:  J Cell Mol Med       Date:  2020-02-17       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.